AKUMS DRUGS AND PHARMA L Valuation

AKUMS · Healthcare · Current price ₹780.85

Full stock page
DocStoX fair value
₹430
low confidence
Current price
₹781
Upside
-44.9%
P/E ratio
48.2x
P/B ratio
3.0x
Verdict
Avoid
Model it yourself — Earnings Yield Calculator
Opens pre-filled with AKUMS DRUGS AND PHARMA L's latest numbers.

Is AKUMS DRUGS AND PHARMA L undervalued?

DocStoX estimates the fair value of AKUMS DRUGS AND PHARMA L at ₹430 per share, versus the current market price of ₹781. That puts the stock about -44.9% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹203), Relative P/E (₹634), Graham floor (₹277), Analyst target (₹863). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹203 (bear) to ₹430 (base) to ₹863 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Valuation multiples

AKUMS DRUGS AND PHARMA L trades at a P/E of 48.2x and a P/B of 3.0x, with a dividend yield of 0.4%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.

Understand the ratios

P/E RatioP/B RatioPEG RatioEarnings Yield

More on AKUMS DRUGS AND PHARMA L

Fair ValueIntrinsic ValueDCFFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.